Drug Shortage Report for JAMP-GABAPENTIN
| Report ID | 180277 |
| Drug Identification Number | 02361493 |
| Brand name | JAMP-GABAPENTIN |
| Common or Proper name | Gabapentin Capsules |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | GABAPENTIN |
| Strength(s) | 400MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2022-12-09 |
| Estimated end date | 2023-02-10 |
| Actual end date | 2023-01-27 |
| Shortage status | Resolved |
| Updated date | 2023-01-31 |
| Company comments | Disruption of the manufacture of the drug. Other size available. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2023-01-31 | French | Compare |
| v5 | 2023-01-31 | English | Compare |
| v4 | 2023-01-10 | French | Compare |
| v3 | 2023-01-10 | English | Compare |
| v2 | 2023-01-09 | French | Compare |
| v1 | 2023-01-09 | English | Compare |
Showing 1 to 6 of 6